Your browser doesn't support javascript.
loading
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Huang, Kun; Zapata, Daniel; Tang, Yan; Teng, Yong; Li, Yamin.
Affiliation
  • Huang K; Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.
  • Zapata D; Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.
  • Tang Y; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. Electronic address: yong.teng@emory.edu.
  • Li Y; Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. Electronic address: liyam@upstate.edu.
Biomaterials ; 291: 121876, 2022 12.
Article in En | MEDLINE | ID: mdl-36334354

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Biomaterials Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Biomaterials Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands